Profile | GDS5420 / 206637_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 415.48 | 64 |
GSM1296119 | B_lesional_pre-dose | 1847.51 | 88 |
GSM1296076 | C_lesional_pre-dose | 1626.72 | 86 |
GSM1296092 | D_lesional_pre-dose | 924.86 | 78 |
GSM1296103 | E_lesional_pre-dose | 528.65 | 69 |
GSM1296078 | F_lesional_pre-dose | 1200.88 | 81 |
GSM1296107 | G_lesional_pre-dose | 1321.5 | 84 |
GSM1296109 | H_lesional_pre-dose | 724.13 | 74 |
GSM1296080 | I_lesional_pre-dose | 611.51 | 71 |
GSM1296090 | J_lesional_pre-dose | 1829.32 | 87 |
GSM1296074 | K_lesional_pre-dose | 1087.77 | 80 |
GSM1296111 | L_lesional_pre-dose | 2017.3 | 89 |
GSM1296099 | M_lesional_pre-dose | 1072.67 | 80 |
GSM1296086 | O_lesional_pre-dose | 1083.99 | 80 |
GSM1296117 | P_lesional_pre-dose | 1201.58 | 82 |
GSM1296113 | Q_lesional_pre-dose | 1822.97 | 89 |
GSM1296096 | R_lesional_pre-dose | 996.46 | 79 |
GSM1296105 | S_lesional_pre-dose | 1807.78 | 88 |
GSM1296098 | T_lesional_pre-dose | 307.03 | 59 |
GSM1296101 | U_lesional_pre-dose | 909.74 | 78 |
GSM1296121 | V_lesional_pre-dose | 1176.98 | 82 |
GSM1296088 | W_lesional_pre-dose | 1557.05 | 86 |
GSM1296082 | X_lesional_pre-dose | 956.64 | 78 |
GSM1296115 | Y_lesional_pre-dose | 1312.89 | 84 |
GSM1296084 | Z_lesional_pre-dose | 799.47 | 75 |
GSM1296072 | B_lesional_day8 | 1901.14 | 89 |
GSM1296069 | L_lesional_day8 | 1153.93 | 82 |
GSM1296071 | P_lesional_day8 | 2874.69 | 94 |
GSM1296070 | Y_lesional_day8 | 2777.17 | 94 |
GSM1296073 | V_lesional_day8 | 1442.88 | 84 |
GSM1296034 | A_lesional_day15 | 597.31 | 70 |
GSM1296041 | G_lesional_day15 | 1425.68 | 85 |
GSM1296035 | R_lesional_day15 | 996.34 | 79 |
GSM1296038 | U_lesional_day15 | 1351.41 | 84 |
GSM1296047 | B_lesional_day15 | 1995.52 | 90 |
GSM1296039 | E_lesional_day15 | 1292.78 | 83 |
GSM1296042 | H_lesional_day15 | 3191.54 | 95 |
GSM1296043 | L_lesional_day15 | 1287.2 | 84 |
GSM1296037 | M_lesional_day15 | 1231.84 | 83 |
GSM1296046 | P_lesional_day15 | 2231.92 | 91 |
GSM1296044 | Q_lesional_day15 | 2070.88 | 90 |
GSM1296045 | Y_lesional_day15 | 3301.06 | 95 |
GSM1296025 | C_lesional_day15 | 1832.58 | 88 |
GSM1296033 | D_lesional_day15 | 1445.9 | 85 |
GSM1296027 | I_lesional_day15 | 2045.46 | 89 |
GSM1296032 | J_lesional_day15 | 1583.81 | 86 |
GSM1296024 | K_lesional_day15 | 2178.9 | 90 |
GSM1296031 | W_lesional_day15 | 2273.55 | 91 |
GSM1296028 | X_lesional_day15 | 1298.43 | 83 |
GSM1296029 | Z_lesional_day15 | 1475.6 | 85 |
GSM1296026 | F_lesional_day15 | 1208.18 | 82 |
GSM1296030 | O_lesional_day15 | 1696.95 | 86 |
GSM1296040 | S_lesional_day15 | 899.74 | 77 |
GSM1296036 | T_lesional_day15 | 427.43 | 64 |
GSM1296048 | V_lesional_day15 | 2458.87 | 91 |
GSM1296059 | A_lesional_day43 | 547.78 | 69 |
GSM1296066 | G_lesional_day43 | 1445.41 | 85 |
GSM1296060 | R_lesional_day43 | 1213.85 | 82 |
GSM1296063 | U_lesional_day43 | 2245.24 | 90 |
GSM1296064 | E_lesional_day43 | 978.97 | 79 |
GSM1296067 | H_lesional_day43 | 2681.6 | 94 |
GSM1296062 | M_lesional_day43 | 522.85 | 68 |
GSM1296068 | Q_lesional_day43 | 2029.41 | 90 |
GSM1296050 | C_lesional_day43 | 2705.88 | 92 |
GSM1296057 | D_lesional_day43 | 1399.79 | 84 |
GSM1296052 | I_lesional_day43 | 2253.72 | 90 |
GSM1296054 | J_lesional_day43 | 1812.69 | 88 |
GSM1296049 | K_lesional_day43 | 1795.66 | 88 |
GSM1296055 | W_lesional_day43 | 1998.31 | 89 |
GSM1296053 | X_lesional_day43 | 1451.02 | 85 |
GSM1296058 | Z_lesional_day43 | 940.96 | 78 |
GSM1296051 | F_lesional_day43 | 1564.68 | 85 |
GSM1296056 | O_lesional_day43 | 1554.39 | 85 |
GSM1296065 | S_lesional_day43 | 1341.91 | 84 |
GSM1296061 | T_lesional_day43 | 425.23 | 64 |
GSM1296095 | A_non-lesional_pre-dose | 1630.84 | 86 |
GSM1296120 | B_non-lesional_pre-dose | 2198.6 | 91 |
GSM1296077 | C_non-lesional_pre-dose | 1833.92 | 88 |
GSM1296093 | D_non-lesional_pre-dose | 1229.48 | 83 |
GSM1296104 | E_non-lesional_pre-dose | 1467.67 | 85 |
GSM1296079 | F_non-lesional_pre-dose | 1508.43 | 85 |
GSM1296108 | G_non-lesional_pre-dose | 1456.52 | 85 |
GSM1296110 | H_non-lesional_pre-dose | 2883.66 | 94 |
GSM1296081 | I_non-lesional_pre-dose | 2024.8 | 89 |
GSM1296091 | J_non-lesional_pre-dose | 1523.28 | 85 |
GSM1296075 | K_non-lesional_pre-dose | 2909.74 | 93 |
GSM1296112 | L_non-lesional_pre-dose | 1219.1 | 83 |
GSM1296100 | M_non-lesional_pre-dose | 788.53 | 75 |
GSM1296087 | O_non-lesional_pre-dose | 2260.27 | 90 |
GSM1296118 | P_non-lesional_pre-dose | 1405.94 | 85 |
GSM1296114 | Q_non-lesional_pre-dose | 2429.42 | 92 |
GSM1296097 | R_non-lesional_pre-dose | 1730.55 | 87 |
GSM1296106 | S_non-lesional_pre-dose | 1754.06 | 88 |
GSM1296102 | U_non-lesional_pre-dose | 1739.87 | 88 |
GSM1296122 | V_non-lesional_pre-dose | 1608.16 | 87 |
GSM1296089 | W_non-lesional_pre-dose | 1811.95 | 88 |
GSM1296083 | X_non-lesional_pre-dose | 1531.25 | 86 |
GSM1296116 | Y_non-lesional_pre-dose | 1936.62 | 90 |
GSM1296085 | Z_non-lesional_pre-dose | 1056.16 | 80 |